Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform

BACKGROUND: There are an estimated 200,000 to 400,000 cases of visceral leishmaniasis (VL) annually. A variety of factors are taken into account when considering the best therapeutic options to cure a patient and reduce the risk of resistance, including geographical area, malnourishment and HIV coin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bush, Jacob T., Wasunna, Monique, Alves, Fabiana, Alvar, Jorge, Olliaro, Piero L., Otieno, Michael, Sibley, Carol Hopkins, Strub Wourgaft, Nathalie, Guerin, Philippe J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600407/
https://www.ncbi.nlm.nih.gov/pubmed/28873394
http://dx.doi.org/10.1371/journal.pntd.0005781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600407/
https://www.ncbi.nlm.nih.gov/pubmed/28873394
http://dx.doi.org/10.1371/journal.pntd.0005781

Ejemplares similares